Topic: Awards
11.09.2025Gabriele Inchingolo, Ph.D. student in Prof. Luca Gattinoni’s lab at the Leibniz Institute for Immunotherapy, has been selected as one of the winners of Bruker’s inaugural Beacon Discovery Global Grant Program.
Gabriele Inchingolo, Ph.D. student in Prof. Luca Gattinoni’s lab at the Leibniz Institute for Immunotherapy, has been selected as one of the winners of Bruker’s inaugural Beacon Discovery Global Grant Program.
Julia Englbrecht, a doctoral student at the Research Group “Epigenetic Immuno-oncology”, headed by Dr. Christian Schmidl, has been awarded the highly competitive doctoral scholarship by the “Studienstiftung des deutschen Volkes”.
PhD students from the Leibniz Institute for Immunotherapy (LIT) took part in the Summer School organized by the Regensburg International Graduate School of Life Sciences (RIGeL). Meghma Mukherjee has received the Best Poster Award, while Fabian Hölzl has been awarded the Best Questioner Prize. Dr. Christian Schmidl contributed as a guest lecturer at the event.
A publication on the hidden potential of the gene LMO4 to enhance the cancer-fighting abilities of T cells has been selected as the “Highlight of Biomedical Research” in July by the Medical Faculty of the University of Regensburg. The study authored by LIT researchers Dr. Dr. Roland Schelker, head of the Clinical Translation Group “T-Cell Fitness” at the LIT and specialist in hematology/oncology at the University Hospital Regensburg, and Prof. Luca Gattinoni, Head of LIT Research Division “Functional Immune Cell Modulation”, was published in the high-impact journal Signal Transduction and Targeted Therapy.
LIT scientist Meghma Mukherjee, PhD student at the Research Division “Interventional Immunology” headed by Prof. Philipp Beckhove, received the Best Poster Award at the CIMT Annual Meeting in Mainz.
Dr. Jeremy Baldwin, Postdoctoral Scientist in the Functional Immune Cell Modulation Division of the LIT, received an Add-on Fellowships for Interdisciplinary Life Science of 12.500€ by the Joachim Herz Foundation for his research project on metabolically reprogramming CD8+ T cells for cancer immunotherapy applications.
The award-winning work from Dr. Christian Schmidl’s group investigates epigenetic changes in tumor-infiltrating T cells that distinguish functional from dysfunctional (“exhausted”) T cells.
The prestigious Johann Georg Zimmermann Medal was awarded this year to LIT scientist Prof. Hinrich Abken in recognition of his lifetime achievements.
Dr. Bittner developed a new type of synthetic biosensor, so-called artificial immune receptors (AIRs), with the help of which Treg cells can be reprogrammed into intelligent ‘smart’ Tregs.
RCI scientist Valentina Volpin, Ph.D, has received the 2021 CMIT Audience Choice award for her e-talk.